Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital

Japanese Journal of Infectious Diseases

Volumn 65, Issue 1, 2012, Pages 66-71

  Aydemir, Hande ^a   Celebi, Guven ^a   Piskin, Nihal ^a   Oztoprak, Nefise ^a   Keskin, Aysegul Seremet ^a   Aktas, Elif ^a   Sumbuloglu, Vildan ^b   Akduman, Deniz ^a  

^a Department of Infectious Diseases and Clinical Microbiology ^*  (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; CARBAPENEM; IMIPENEM; MEROPENEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PENICILLINS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 84856346508     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Van Looveren, M., Goossens, H., ARPAC Steering Group (2004): Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect., 10, 684-704.
2. Boots, R.-J., Lipman, J., Bellomo, R., et al. (2005): Disease risk and mortality prediction in intensive care patients with pneumonia. Australian and New Zealand Practice in Intensive Care (ANZPIC II). Anaesth. Intens. Care, 33, 101-111.
3. Cisneros, J.-M., Reyes, M.-J., Pachoán, J., et al. (1996): Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and clinical findings, and prognostic features. Clin. Infect. Dis., 22, 1026-1032.
4. Niederman, M.-S. (2001): Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit. Care Med., 29 (4 Suppl), N114-120.
5. Fagon, J.-Y., Chastre, J., Hance, A.J., et al. (1993): Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med., 94, 281-288.
6. Garnacho, J., Sole-Violan, J., Sa-Borges, M., et al. (2003): Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit. Care Med., 31, 2478-2482.
7. Tilley, P.A. and Roberts, F.-J. (1994): Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin. Infect. Dis., 18, 896-900.
8. Vidal, F., Mensa, J., Almela, M., et al. (2003): Bacteremia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. Q. J. Med., 96, 227-234.
9. Falagas, M.-E. and Rafailidis, P.-I. (2007): Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit. Care, 11, 134.
10. Bergogne-Beáreázin, E. and Towner, K.-J. (1996): Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev., 9, 148-165.
11. Corbella, X., Montero, A., Pujol, M., et al. (2000): Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol., 38, 4086-4095.
12. Fierobe, L., Lucet, J.-C., Decre, D., et al. (2001): An outbreak of imipenem resistant Acinetobacter baumannii in critically ill surgical patients. Infect. Control Hosp. Epidemiol., 22, 35-40.
13. Levin, A.-S., Mendes, C.-M., Sinto, S.-I., et al. (1996): An outbreak of multiresistant Acinetobacter baumannii in a university hospital in, Saã o Paulo, Brazil. Infect. Control Hosp. Epidemiol., 17, 366-368.
14. Wong, T.-H., Tan, B.-H., Ling, M.L., et al. (2002): Multiresistant Acinetobacter baumannii on a burns unit-clinical risk factors and prognosis. Burns, 28, 349-357.
15. Baran, G., Erbay, A., Bodur, H., et al. (2008): Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int. J. Infect. Dis., 16-21.
16. Garner, J.-S., Jarvis, M.-R., Emori, T.G., et al. (1988): CDC definitions for nosocomial infections. Am. J. Infect. Control, 16, 128-140.
17. Horan, T.C., Gaynes, R.-P., Martone, W.-J., et al. (1992): CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol., 13, 606-608.
18. Schreckenberger, P.C., Daneshvar, M.I., Weyant, R.S., et al. (2003): Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and Other Nonfermentative Gram-negative Rods. p. 749-779. In Murray, P.R., Baron, E.J., Pfaller, M.A., et al. (ed.), Manual of Clinical Microbiology. American Society for Microbiology, Washington, DC.
19. Clinical and Laboratory Standards Institute (2006): Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, Pa, USA.
20. Falagas, M.-E., Bliziotis, I.-A. and Siempos, I.-I. (2006): Attributable mortality of Acinetobacter baumannii infections in critically ill patients. A systematic review of matched cohort and case-control studies. Crit. Care, 10, R48.
21. Gaynes, R. and Edwards, J.-R. (2005): Overview of nosocomial infections caused by Gram-negative bacilli. Clin. Infect. Dis., 41, 848-854.
22. Kanafani, Z.A., Kara, L. and Hayek, S. (2003): Ventilator-associated pneumonia at a tertiary-care center in a developing coun try: incidence, microbiology, and susceptibility patterns of isolated microorganisms. Infect. Control Hosp. Epidemiol., 24, 864-869.
23. Paul, M., Weinberger, M., Siegman-Igra, Y., et al. (2005): Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J. Hosp. Infect., 60, 256-260.
24. Wisplinghoff, H., Bischoff, T., Tallent, S.-M., et al. (2004): Nosocomial bloodstream infections in US hospitals: analysis of 24179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis., 39, 309-317.
25. Cisneros, J.-M., Rodriguez-Banão, J., Fernaá ndez-Cuenca, F., et al. (2005): Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin. Microbiol. Infect., 11, 874-879.
26. Harbath, S., Nobre, V. and Pittet, D. (2007): Does antibiotic selection impact patient outcome? Clin. Infect. Dis., 44, 87-93.
27. Garnacho-Montero, J., Ortiz-Leyba, C., Fernandez-Hinojosa, E., et al. (2005): Acinetobacter baumannii ventilator associated pneumonia: epidemiological and clinical findings. Intensive Care Med., 31, 649-655.
28. Wisplinghoff, H., Edmond, M.B., Pfaller, M.-A., et al. (2000): Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin. Infect. Dis., 31, 690-697.
29. Scerpella, E.-G., Wanger, A.R., Armitige, L., et al. (1995): Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect. Control Hosp. Epidemiol., 16, 92-97.
30. Weingarten, C.-M., Rybak, M.-J., Jahns, B.-E., et al. (1999): Evaluation of Acinetobacter baumannii infection and colonization and antimicrobial treatment patterns in an urban teaching hospital. Pharmacotherapy, 19, 1080-1085.
31. Grupper, M., Sprecher, H., Mashiach, T., et al. (2007): Attributable mortality of nosocomial Acinetobacter bacteremia. Infect. Control Hosp. Epidemiol., 28, 293-298.
32. Robenshtok, E., Paul, M., Leibovici, L., et al. (2006): The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J. Hosp. Infect., 64, 282-287.
33. Sunenshine, R.-H., Wright, M.O., Maragakis, L.L., et al. (2007): Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis., 13, 97-103.
34. del Mar Tomas, M., Cartelle, M., Pertega, S., et al. (2005): Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk factors for colonisation and infection. Clin. Microbiol. Infect., 11, 540-546.
35. Jamulitrat, S., Arunpan, P. and Phainuphong, P. (2009): Attributable mortality of imipenem resistant nosocomial Acinetobacter baumannii bloodstream infection. J. Med. Assoc. Thai, 92, 413-419.
36. Sheng,W.H., Liao, C.H., Lauderdale, T.L., et al. (2010): A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int. J. Infect. Dis., 14, 764-769.
37. Routsi, C., Pratikaki, M., Platsouka, E., et al. (2010): Carbapenem- resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection, 38, 173-180.
38. Playford, E.-G., Craig, J.-C. and Iredell, J.-R. (2007): Carbapenem- resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect., 65, 204-211.
39. Jamulitrat, S., Thongpiyapoom, S. and Suwalak, N. (2007): An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind hospital: the risk factors and patient prognosis. J. Med. Assoc. Thai, 90, 2181-2191.
40. Lee, S.O., Kim, N.-J., Choi, S.-H., et al. (2004): Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case control study. Antimicrob. Agents Chemother., 48, 224-228.